adenosine monophosphate has been researched along with pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clay, A; Katchanov, G; Pelleg, A; Xu, J | 1 |
| Gomez De Aranda, I; Marti, E; Mateo, J; Miras-Portugal, MT; Rotllan, P; Solsona, C | 1 |
| Boudier, HA; De Mey, JG; Rahn, KH; Schlatter, E; Steinmetz, M | 1 |
| Kimura, J; Matsuoka, I; Ohkubo, S | 2 |
| Claes, P; Grobben, B; Roymans, D; Slegers, H; Van Kolen, K | 1 |
| Hoyle, CH; Martín, S; Peláez, T; Peral, A; Pintor, J | 1 |
| Hiken, JF; Steinberg, TH | 1 |
| Boehm, S; Dorostkar, MM; Edelbauer, H; Lechner, SG; Mayer, M; Pankevych, H | 1 |
| Cronin, C; Gongora Nieto, M; Harrison, D; Jacobson, KA; Joshi, BV; Liang, BT; Shen, JB; Sonin, D | 1 |
10 other study(ies) available for adenosine monophosphate and pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
| Article | Year |
|---|---|
Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in the dog. IV. Role of LV vagal afferents.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Afferent Pathways; Animals; Coronary Vessels; Dogs; Female; Heart; Heart Atria; Heart Rate; Injections, Intra-Arterial; Male; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Reflex; Vagotomy; Vagus Nerve | 1997 |
Diadenosine polyphosphate hydrolase from presynaptic plasma membranes of Torpedo electric organ.
Topics: Acid Anhydride Hydrolases; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cations, Divalent; Diethyl Pyrocarbonate; Dinucleoside Phosphates; Electric Organ; Enzyme Inhibitors; Hydrogen-Ion Concentration; Kinetics; Nerve Tissue Proteins; Presynaptic Terminals; Pyridoxal Phosphate; Torpedo | 1997 |
Diadenosine polyphosphates cause contraction and relaxation in isolated rat resistance arteries.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Dinucleoside Phosphates; Endothelium, Vascular; Epigastric Arteries; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Receptors, Purinergic P2; Sympathectomy; Vascular Resistance | 2000 |
Correlation between adenine nucleotide-induced cyclic AMP elevation and extracellular adenosine formation in NG108-15 cells.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cell Membrane; Chromatography, High Pressure Liquid; Cyclic AMP; Enzyme Inhibitors; Extracellular Space; Nucleotidases; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2000 |
Ecto-alkaline phosphatase in NG108-15 cells : a key enzyme mediating P1 antagonist-sensitive ATP response.
Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Cyclic AMP; Gene Expression Regulation, Enzymologic; Glycerophosphates; Hydrogen-Ion Concentration; Hydrolysis; Levamisole; Mice; Organophosphates; Purinergic P1 Receptor Antagonists; Pyridoxal Phosphate; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substrate Specificity; Time Factors; Tumor Cells, Cultured | 2000 |
P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cell Division; Dinucleoside Phosphates; Enzyme Activation; Glioma; Hydrolysis; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Purinergic P2 Receptor Agonists; Pyridoxal Phosphate; Rats; Receptors, Purinergic P2; Thionucleotides; Time Factors; Triazines; Tumor Cells, Cultured | 2001 |
Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Intraocular Pressure; Kinetics; Male; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rabbits; Structure-Activity Relationship; Suramin; Triazines | 2003 |
ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Carrier Proteins; Cell Differentiation; Cell Line; Extracellular Space; Fluorescent Antibody Technique; Giant Cells; Macrophages; Membrane Glycoproteins; Mice; NF-kappa B; Osteoclasts; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Up-Regulation | 2004 |
Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y receptor-mediated inhibition of voltage-gated Ca2+ channels.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adenosine Monophosphate; Animals; Animals, Newborn; Cadmium; Calcium Channels; Cells, Cultured; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Ganglia, Sympathetic; Membrane Potentials; Membrane Proteins; Neural Inhibition; Neurons; Norepinephrine; Patch-Clamp Techniques; PC12 Cells; Pertussis Toxin; Phenethylamines; Potassium; Purine Nucleotides; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Suramin; Thionucleosides; Tritium | 2004 |
P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Benzenesulfonates; Calsequestrin; Cardiac Output, Low; Cardiomyopathies; Disease Models, Animal; Disease Progression; Membrane Potentials; Mice; Mice, Transgenic; Myocytes, Cardiac; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X4; Thionucleotides | 2007 |